Literature DB >> 23704457

Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction.

Sameera Mohamed Ali1, Ali Raza Rajani, Fahad Omar Baslaib.   

Abstract

Intracranial haemorrhage is a known complication after fibrinolytic therapy and occurs usually in the first 24 h. We report a 35-year-old woman who presented with severe central chest pain and she was diagnosed as anterior ST elevation myocardial infarction. She was given fibrinolytic therapy with Tenecteplase. She responded well to the treatment with a decrease in the intensity of chest pain and resolution of the ST segment elevation. She was taken for coronary angiogram the next day, which revealed an occlusion of the left anterior descending (LAD) artery, and stenting of LAD was carried out. Four days later, she developed severe headache, confusion, slurring of speech and right haemiparesis. CT brain revealed intracerebral haemorrhage and she was referred to an neurosurgeon who advised for conservative management. Her condition gradually improved with physiotherapy and was discharged home with no marked functional impairment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23704457      PMCID: PMC3669972          DOI: 10.1136/bcr-2013-009816

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Familial aggregation of early-onset myocardial infarction.

Authors:  Valentina Cipriani; Pier M Mannucci; Diego Ardissino; Maurizio Ferrario; Giancarlo Corsini; Piera Angelica Merlini; Francesca Notarangelo; Daniela Lina; Luisa Bernardinelli
Journal:  Eur J Intern Med       Date:  2010-08-25       Impact factor: 4.487

Review 2.  Cardiovascular disease in women.

Authors:  E D Eaker; J H Chesebro; F M Sacks; N K Wenger; J P Whisnant; M Winston
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

3.  Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis.

Authors:  Erin D Michos; Chandrasekhar R Vasamreddy; Diane M Becker; Lisa R Yanek; Taryn F Moy; Elliot K Fishman; Lewis C Becker; Roger S Blumenthal
Journal:  Am Heart J       Date:  2005-12       Impact factor: 4.749

Review 4.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.

Authors:  C Noel Bairey Merz; Leslee J Shaw; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Carl J Pepine; Sunil Mankad; Barry L Sharaf; William J Rogers; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

5.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

6.  Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Authors: 
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

7.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).

Authors:  F H Zimmerman; A Cameron; L D Fisher; G Ng
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

8.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

9.  Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

Authors:  J H Gurwitz; J M Gore; R J Goldberg; H V Barron; T Breen; A C Rundle; M A Sloan; W French; W J Rogers
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

Review 10.  Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.

Authors:  Daniel E Hilleman; James P Tsikouris; A Allen Seals; Jonathan D Marmur
Journal:  Pharmacotherapy       Date:  2007-11       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.